FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Günter Steiner

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Biological Markers

Co-author Network

Publications

TOP 3
Sonja Herman; Martin Herrmann; Rikard Holmdahl; Angelika Kny; Birgit Niederreiter; Jürgen Pfatschbacher; Christine Schorn; Günter Steiner; Markus H Hoffmann
Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils.
Thomas Karonitsch; Hans P Kiener; Josef S Smolen; Carl Walter STEINER; Günter Steiner; Karolina von Dalwigk; Stephan Blüml; Martin Aringer
Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis.
Johannes Grisar; Marion Ronit Munk; L Amoyo-Minar; Carl Walter STEINER; Günter Steiner; Makiyeh Tohidast-Akrad; P Zenz; Josef S Smolen
Expression patterns of CD44 and CD44 splice variants in patients with rheumatoid arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Günter Steiner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sonja Herman; Martin Herrmann; Rikard Holmdahl; Angelika Kny; Birgit Niederreiter; Jürgen Pfatschbacher; Christine Schorn; Günter Steiner; Markus H Hoffmann
Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils.
Autoimmunity 2012;45(8):602-11.
2012: Thomas Karonitsch; Hans P Kiener; Josef S Smolen; Carl Walter STEINER; Günter Steiner; Karolina von Dalwigk; Stephan Blüml; Martin Aringer
Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis.
Arthritis and rheumatism 2012;64(2):400-8.
2012: Johannes Grisar; Marion Ronit Munk; L Amoyo-Minar; Carl Walter STEINER; Günter Steiner; Makiyeh Tohidast-Akrad; P Zenz; Josef S Smolen
Expression patterns of CD44 and CD44 splice variants in patients with rheumatoid arthritis.
Clinical and experimental rheumatology 2012;30(1):64-72.
2010: Sylvie Trembleau; Markus Hoffmann; Brigitte Meyer; Valerie Nell Duxneuner; Helga Radner; Wolfgang Zauner; Juergen Hammer; Gerald Aichinger; Gottfried Fischer; Josef Smolen; Günter Steiner
Immunodominant T-cell epitopes of hnRNP-A2 associated with disease activity in patients with rheumatoid arthritis.
European journal of immunology 2010;40(6):1795-808.
2010: Markus H Hoffmann; Sylvie Trembleau; Sylviane Muller; Günter Steiner
Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential.
Journal of autoimmunity 2010;34(3):J178-206.
2010: Markus H Hoffmann; Rudolf Hopf; Birgit Niederreiter; Heinz Redl; Josef S Smolen; Günter Steiner
Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis.
Arthritis research & therapy 2010;12(2):R41.
2010: V Nell-Duxneuner; K Machold; Tanja A Stamm; Gabriele J M Eberl; H Heinzl; E Hoefler; Josef S Smolen; Günter Steiner
Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study.
Annals of the rheumatic diseases 2010;69(1):169-74.
2009: Pamina Pflegerl; Paul Vesely; Brigitte Hantusch; Michaela Schlederer; Rainer Zenz; Elke Janig; Günter Steiner; Arabella Meixner; peter petzelbauer; Peter Wolf; Afschin Soleiman; Gerda Egger; Richard Moriggl; Tadamitsu Kishimoto; Erwin F Wagner; Lukas Kenner
Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(48):20423-8.
2009: Sergio Generini; Günter Steiner; Irene Miniati; Maria Letizia Conforti; Serena Guiducci; Karl Skriner; O Kaloudi; Roberto Giacomelli; Josef Smolen; Marco Matucci-Cerinic
Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement.
Rheumatology (Oxford, England) 2009;48(8):920-5.
2009: Thomas Karonitsch; Eva Feierl; Carl Walter STEINER; Karolina Dalwigk; Adelheid Korb; Nikolaus Binder; Alfred Rapp; Günter Steiner; Clemens Scheinecker; Josef Smolen; Martin Aringer
Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.
Arthritis and rheumatism 2009;60(5):1463-71.
2009: Georg Schett; Hélène Dumortier; E Hoefler; Sylviane Muller; Günter Steiner
B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease.
Annals of the rheumatic diseases 2009;68(5):729-35.
2009: Josef S Smolen; Daniel Aletaha; Günter Steiner
Does damage cause inflammation? Revisiting the link between joint damage and inflammation.
Annals of the rheumatic diseases 2009;68(2):159-62.
2008: J Grisar; Carl Walter STEINER; M Bonelli; T Karonitsch; Ilse Schwarzinger; G Weigel; Günter Steiner; Josef S Smolen
Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells.
Rheumatology (Oxford, England) 2008;47(10):1476-83.
2008: Esther Jimenez-Boj; Nancy Kedersha; Makiyeh Tohidast-Akrad; Franz M Karlhofer; Georg Stummvoll; Christof Zimmermann; Walter Ulrich; Serena Guiducci; Elisabeth Hoefler; Martin Aringer; Georg Schett; Marco Matucci-Cerinic; Josef S Smolen; Günter Steiner
Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Arthritis and rheumatism 2008;58(5):1226-36.
2008: Karl Skriner; Wolfgang Hueber; Erhan Süleymanoglu; Elisabeth Höfler; Veit Krenn; Josef Smolen; Günter Steiner
AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases.
Arthritis and rheumatism 2008;58(2):511-20.
2008: Josef S Smolen; Daniel Aletaha; Johannes Grisar; Kurt Redlich; Günter Steiner; Oswald Wagner
The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?
Arthritis research & therapy 2008;10(3):208.
2007: Markus H Hoffmann; Jonatan Tuncel; Karl Skriner; Makiyeh Tohidast-Akrad; Birgit Türk; Serafin Pinol-Roma; Guy Serre; Georg Schett; Josef S Smolen; Rikard Holmdahl; Günter Steiner
The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(11):7568-76.
2007: Johannes Grisar; Daniel Aletaha; Carl Walter STEINER; Theresa Kapral; Sabine Steiner; Marcus D Säemann; Ilse Schwarzinger; Barbara Buranyi; Günter Steiner; Josef S Smolen
Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy.
Annals of the rheumatic diseases 2007;66(10):1284-8.
2007: Günter Steiner
Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools.
Clinical reviews in allergy & immunology 2007;32(1):23-36.
2007: Klaus P Machold; Tanja A Stamm; Valerie Nell Duxneuner; Stephan Pflugbeil; Daniel Aletaha; Günter Steiner; Martin Uffmann; Josef S Smolen
Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.
Rheumatology (Oxford, England) 2007;46(2):342-9.
2007: Martin Aringer; Günter Steiner; Wolfgang Graninger; Elisabeth Höfler; Carl Walter STEINER; Josef S Smolen
Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus.
Arthritis and rheumatism 2007;56(1):274-9.
2006: Ruth Fritsch-Stork; Daniela Müllegger; Karl Skriner; Beatrice Jahn-Schmid; Josef S Smolen; Günter Steiner
The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
Arthritis research & therapy 2006;8(4):R118.
2005: Silvia Hayer; Makiyeh Tohidast-Akrad; Sylva Haralambous; Beatrice Jahn-Schmid; Karl Skriner; Sylvie Trembleau; Hélène Dumortier; Serafin Pinol-Roma; Kurt Redlich; Georg Schett; Sylviane Muller; george kollias; Josef Smolen; Günter Steiner
Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(12):8327-36.
2005: Valerie Nell Duxneuner; Klaus P Machold; Tanja A Stamm; Gabriele J M Eberl; H Heinzl; Martin Uffmann; Josef S Smolen; Günter Steiner
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(12):1731-6.
2005: Martin Aringer; Günter Steiner; Josef S Smolen
Does mixed connective tissue disease exist? Yes.
Rheumatic diseases clinics of North America 2005;31(3):411-20, v.
2005: Aurélia Belisova; Katharina Semrad; Oliver Mayer; Grazia Kocian; Elisabeth Waigmann; Renée Schroeder; Günter Steiner
RNA chaperone activity of protein components of human Ro RNPs.
RNA (New York, N.Y.) 2005;11(7):1084-94.
2005: Josef S Smolen; Kurt Redlich; Jochen Zwerina; Daniel Aletaha; Günter Steiner; Georg Schett
Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspects.
Clinical reviews in allergy & immunology 2005;28(3):239-48.
2005: Silvia Hayer; Günter Steiner; Birgit Görtz; Erika Reiter; Makiyeh Tohidast-Akrad; Michael Amling; Oskar Hoffmann; Kurt Redlich; Jochen Zwerina; Karl Skriner; Frank Hilberg; Erwin F Wagner; Josef S Smolen; Georg Schett
CD44 is a determinant of inflammatory bone loss.
The Journal of experimental medicine 2005;201(6):903-14.
2005: Johannes Grisar; Daniel Aletaha; Carl Walter STEINER; Theresa Kapral; Sabine Steiner; Daniela Seidinger; Guenter Weigel; Ilse Schwarzinger; Wolfgang Wolozcszuk; Günter Steiner; Josef S Smolen
Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis.
Circulation 2005;111(2):204-11.
2005: Josef S Smolen; Günter Steiner; Martin Aringer
Anti-cytokine therapy in systemic lupus erythematosus.
Lupus 2005;14(3):189-91.
2005: Marcus Köller; Silvia Hayer; Kurt Redlich; Romeo Ricci; Jean-Pierre David; Günter Steiner; Josef S Smolen; Erwin F Wagner; Georg Schett
JNK1 is not essential for TNF-mediated joint disease.
Arthritis research & therapy 2005;7(1):R166-73.
2004: Marcus Köller; Bettina Zwölfer; Günter Steiner; Josef S Smolen; Clemens Scheinecker
Phenotypic and functional deficiencies of monocyte-derived dendritic cells in systemic lupus erythematosus (SLE) patients.
International immunology 2004;16(11):1595-604.
2004: Martin Aringer; Wolfgang Graninger; Günter Steiner; Josef S Smolen
Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
Arthritis and rheumatism 2004;50(10):3161-9.
2004: J S Smolen; Silvia Hayer; Georg Schett; Kurt Redlich; Martin Aringer; george kollias; E Wagner; Günter Steiner
Autoimmunity and rheumatoid arthritis.
Autoimmunity reviews 2004;3 Suppl 1():S23.
2004: Birgit Görtz; Silvia Hayer; Kurt Redlich; Jochen Zwerina; Makiyeh Tohidast-Akrad; Birgit Tuerk; Christine Hartmann; george kollias; Günter Steiner; Josef S Smolen; Georg Schett
Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(6):990-8.
2004: Kurt Redlich; Birgit Görtz; Silvia Hayer; Jochen Zwerina; george kollias; Günter Steiner; Josef S Smolen; Georg Schett
Overexpression of tumor necrosis factor causes bilateral sacroiliitis.
Arthritis and rheumatism 2004;50(3):1001-5.
2004: Kurt Redlich; Birgit Görtz; Silvia Hayer; Jochen Zwerina; Nicholas Doerr; Paul J Kostenuik; Helga Bergmeister; george kollias; Günter Steiner; Josef S Smolen; Georg Schett
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.
The American journal of pathology 2004;164(2):543-55.
2004: Jochen Zwerina; Silvia Hayer; Makiyeh Tohidast-Akrad; Helga Bergmeister; Kurt Redlich; Ulrich Feige; Colin Dunstan; george kollias; Günter Steiner; Josef Smolen; Georg Schett
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Arthritis and rheumatism 2004;50(1):277-90.
2003: Kurt Redlich; Georg Schett; Günter Steiner; Silvia Hayer; Erwin F Wagner; Josef S Smolen
Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.
Arthritis and rheumatism 2003;48(12):3308-19.
2003: Georg Schett; Carl Walter STEINER; Qingbo Xu; Josef S Smolen; Günter Steiner
TNFalpha mediates susceptibility to heat-induced apoptosis by protein phosphatase-mediated inhibition of the HSF1/hsp70 stress response.
Cell death and differentiation 2003;10(10):1126-36.
2003: Klaus P Machold; Valerie Nell Duxneuner; Tanja A Stamm; Gabriele J M Eberl; Günter Steiner; Josef S Smolen
The Austrian Early Arthritis Registry.
Clinical and experimental rheumatology 2003;21(5 Suppl 31):S113-7.
2003: Georg Schett; Kurt Redlich; Silvia Hayer; Jochen Zwerina; Brad Bolon; Colin Dunstan; Birgit Görtz; Andreas Schulz; Helga Bergmeister; george kollias; Günter Steiner; Josef S Smolen
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.
Arthritis and rheumatism 2003;48(7):2042-51.
2003: Josef S Smolen; Günter Steiner
Therapeutic strategies for rheumatoid arthritis.
Nature reviews. Drug discovery 2003;2(6):473-88.
2002: Kurt Redlich; Silvia Hayer; Romeo Ricci; Jean-Pierre David; Makiyeh Tohidast-Akrad; george kollias; Günter Steiner; Josef S Smolen; Erwin F Wagner; Georg Schett
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
The Journal of clinical investigation 2002;110(10):1419-27.
2002: Ruth Fritsch; Daniela Eselböck; Karl Skriner; Beatrice Jahn-Schmid; Clemens Scheinecker; Barbara Bohle; Makiyeh Tohidast-Akrad; Silvia Hayer; Josef Neumüller; Serafin Pinol-Roma; Josef S Smolen; Günter Steiner
Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(2):1068-76.
2002: Günter Steiner; Ora Shovman; Karl Skriner; Boris Gilburd; Pnina Langevitz; M Miholits; R Hoet; Y Levy; Gisele Zandman-Goddard; E Hoefler; Josef S Smolen; Y Shoenfeld
Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice.
Clinical and experimental rheumatology 2002;20(4):517-24.
2002: Kurt Redlich; Silvia Hayer; Andrea Maier; Colin Dunstan; Makiyeh Tohidast-Akrad; Susanne Lang; Birgit Türk; Peter Pietschmann; Wolfgang Woloszczuk; Sylva Haralambous; george kollias; Günter Steiner; Josef S Smolen; Georg Schett
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.
Arthritis and rheumatism 2002;46(3):785-92.
2002: Georg Schett; J Smole; C Zimmermann; H Hiesberger; E Hoefler; S Fournel; S Muller; R L Rubin; Günter Steiner
The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity.
Lupus 2002;11(11):704-15.
2002: Günter Steiner; Josef Smolen
Autoantibodies in rheumatoid arthritis and their clinical significance.
Arthritis research 2002;4 Suppl 2():S1-5.
2002: Martin Aringer; Eva Feierl; Günter Steiner; Georg H Stummvoll; Elisabeth Höfler; Carl Walter STEINER; I Radda; J S Smole; Wolfgang Graninger
Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death.
Lupus 2002;11(2):102-8.
2001: Georg Schett; Silvia Hayer; Makiyeh Tohidast-Akrad; B J Schmid; Susanne Lang; Birgit Türk; Franz Kainberger; Sylva Haralambous; george kollias; A C Newby; Qingbo Xu; Günter Steiner; Josef Smolen
Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice.
Arthritis and rheumatism 2001;44(12):2888-98.
2001: Fanny Monneaux; Hélène Dumortier; Günter Steiner; Jean-Paul Briand; Sylviane Muller
Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
International immunology 2001;13(9):1155-63.
2001: Martin Aringer; Georg H Stummvoll; Günter Steiner; Marcus Köller; Carl Walter STEINER; Elisabeth Höfler; H Hiesberger; Josef S Smolen; Wolfgang Graninger
Serum interleukin-15 is elevated in systemic lupus erythematosus.
Rheumatology (Oxford, England) 2001;40(8):876-81.
2001: G Fabini; Reinout Raijmakers; Silvia Hayer; Michael A Fouraux; Ger J M Pruijn; Günter Steiner
The heterogeneous nuclear ribonucleoproteins I and K interact with a subset of the ro ribonucleoprotein-associated Y RNAs in vitro and in vivo.
The Journal of biological chemistry 2001;276(23):20711-8.
2001: Kurt Redlich; Hans P Kiener; Georg Schett; Makiyeh Tohidast-Akrad; Edgar Selzer; I Radda; Georg H Stummvoll; Carl Walter STEINER; Marion Gröger; Peter Bitzan; P Zenz; Josef S Smolen; Günter Steiner
Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha.
Arthritis and rheumatism 2001;44(2):266-74.
2001: Georg Schett; Makiyeh Tohidast-Akrad; Günter Steiner; Josef Smolen
The stressed synovium.
Arthritis research 2001;3(2):80-6.
2000: Georg Schett; Makiyeh Tohidast-Akrad; Josef S Smolen; B J Schmid; Carl Walter STEINER; Peter Bitzan; P Zenz; Kurt Redlich; Qingbo Xu; Günter Steiner
Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.
Arthritis and rheumatism 2000;43(11):2501-12.
2000: Hélène Dumortier; Fanny Monneaux; Beatrice Jahn-Schmid; Jean-Paul Briand; Karl Skriner; P L Cohen; Josef S Smolen; Günter Steiner; Sylviane Muller
B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleoproteins A2 and B1 in normal and lupus mice.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(4):2297-305.
2000: G Fabini; SA Rutjes; C Zimmermann; Ger J M Pruijn; Günter Steiner
Analysis of the molecular composition of Ro ribonucleoprotein complexes. Identification of novel Y RNA-binding proteins.
European journal of biochemistry / FEBS 2000;267(9):2778-89.
2000: Georg Schett; R L Rubin; Günter Steiner; H Hiesberger; S Muller; Josef Smolen
The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
Arthritis and rheumatism 2000;43(2):420-8.
2000: Georg Schett; Carl Walter STEINER; S Winkler; Wolfgang Graninger; Josef Smolen; Q Xu; Günter Steiner
[Reciprocal modification of Fas activation and stress protein response decides apoptosis or resistance development of cells].
Acta medica Austriaca 2000;27(3):94-8.
2000: Hans P Kiener; R Hofbauer; Makiyeh Tohidast-Akrad; S Walchshofer; Kurt Redlich; Peter Bitzan; Stylianos Kapiotis; Günter Steiner; Josef S Smolen; Peter Valent
Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis.
Arthritis and rheumatism 2000;43(1):164-74.
1999: Georg Schett; Carl Walter STEINER; Marion Gröger; S Winkler; Wolfgang Graninger; Josef Smolen; Qingbo Xu; Günter Steiner
Activation of Fas inhibits heat-induced activation of HSF1 and up-regulation of hsp70.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1999;13(8):833-42.
1999: Günter Steiner; Makiyeh Tohidast-Akrad; G Witzmann; M Vesely; A Studnicka-Benke; A Gal; M Kunaver; P Zenz; Josef S Smolen
Cytokine production by synovial T cells in rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38(3):202-13.
1998: C Zimmermann; Günter Steiner; K Skriner; W Hassfeld; P Petera; Josef S Smolen
The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
Arthritis and rheumatism 1998;41(11):1938-45.
1998: Georg Schett; Günter Steiner; Josef S Smolen
Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formation.
Arthritis and rheumatism 1998;41(8):1446-55.
1998: Georg Schett; Kurt Redlich; Qingbo Xu; P Bizan; Marion Gröger; Makiyeh Tohidast-Akrad; Hans P Kiener; Josef Smolen; Günter Steiner
Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs.
The Journal of clinical investigation 1998;102(2):302-11.
1998: Josef S Smolen; Günter Steiner
Mixed connective tissue disease: to be or not to be?
Arthritis and rheumatism 1998;41(5):768-77.
1997: K Skriner; W H Sommergruber; V Tremmel; I Fischer; Andrea Barta; Josef S Smolen; Günter Steiner
Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
The Journal of clinical investigation 1997;100(1):127-35.
1996: Günter Steiner; K Skriner; Josef S Smolen
Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases.
International archives of allergy and immunology 1996;111(4):314-9.
1996: A Studnicka-Benke; Günter Steiner; P Petera; Josef S Smolen
Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus.
British journal of rheumatology 1996;35(11):1067-74.
1996: C Zimmermann; Josef S Smolen; Wolfgang Graninger; P Petera; G Fabini; W Hassfeld; E Höfler; Günter Steiner
Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus.
The Journal of rheumatology 1996;23(11):1897-903.
1996: Günter Steiner; K Skriner; W Hassfeld; Josef S Smolen
Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins--a link between RA, SLE and MCTD.
Molecular biology reports 1996;23(3-4):167-71.
1996: Josef S Smolen; Makiyeh Tohidast-Akrad; A Gal; M Kunaver; G Eberl; P Zenz; András Falus; Günter Steiner
The role of T-lymphocytes and cytokines in rheumatoid arthritis.
Scandinavian journal of rheumatology 1996;25(1):1-4.
1995: W Hassfeld; Günter Steiner; A Studnicka-Benke; K Skriner; Wolfgang Graninger; I Fischer; Josef S Smolen
Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus.
Arthritis and rheumatism 1995;38(6):777-85.
1995: Günter Steiner; A Studnicka-Benke; G Witzmann; E Höfler; Josef Smolen
Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
The Journal of rheumatology 1995;22(3):406-12.
1994: K Skriner; Günter Steiner; W H Sommergruber; A Sinski; Josef S Smolen
Anti-RA33 autoantibodies may recognize epitopes in the N-terminal region of hnRNP-A2 (RA33).
Clinical and experimental rheumatology 1994;12 Suppl 11():S79-82.
1993: W Hassfeld; Günter Steiner; W Graninger; G Witzmann; H Schweitzer; Josef S Smolen
Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis.
British journal of rheumatology 1993;32(3):199-203.
1992: Günter Steiner; Klaus Hartmuth; K Skriner; I Maurer-Fogy; A Sinski; E Thalmann; W Hassfeld; Andrea Barta; Josef S Smolen
Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex.
The Journal of clinical investigation 1992;90(3):1061-6.
1990: Josef S Smolen; W Hassfeld; W Graninger; Günter Steiner
Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis.
Clinical and experimental rheumatology 1990;8 Suppl 5():41-4.
1990: H Wilfert; Herbert Hönigsmann; Günter Steiner; Josef Smolen; Klaus Wolff
Treatment of psoriatic arthritis by extracorporeal photochemotherapy.
The British journal of dermatology 1990;122(2):225-32.
1989: W Hassfeld; Günter Steiner; Klaus Hartmuth; Gernot Kolarz; O Scherak; Wolfgang Graninger; N Thumb; Josef S Smolen
Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis.
Arthritis and rheumatism 1989;32(12):1515-20.